467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation

467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation

Bibliographic Details
Main Authors:	Hua Zhong, Huiping Qiang
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands
by: Anneloes L. Noordhof, MD, et al.
Published: (2023-09-01)

Real-World Evidence Study of Patients with <i>KRAS</i>-Mutated NSCLC in Finland
by: Anna Anttalainen, et al.
Published: (2024-05-01)

Efficacy of immunotherapy in KRAS-mutant advanced NSCLC: A real-world study in a Chinese population
by: Lixiu Peng, et al.
Published: (2023-01-01)

Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01)

Clinical Analysis of 107 NSCLC Patients Harboring KRAS Mutation
by: Quan ZHANG, et al.
Published: (2016-05-01)

Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C-Mutated NSCLC
by: Katherine I. Zhou, MD, PhD, et al.
Published: (2024-05-01)

Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome
by: Dan Zhao, et al.
Published: (2024-06-01)

The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy
by: Francis Proulx-Rocray, et al.
Published: (2023-01-01)

Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations
by: Kathryn C. Arbour, MD, et al.
Published: (2022-01-01)

Review of published 467 achondroplasia patients: clinical and mutational spectrum
by: XinZhong Zhang, et al.
Published: (2024-01-01)

Comprehensive analysis of mutations in NSCLC patients in a real-world setting
by: Xinghao Ai, et al.
Published: (2022-07-01)

Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC
by: Parneet K. Cheema, et al.
Published: (2023-07-01)

A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib
by: Brazel D, et al.
Published: (2022-11-01)

Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan
by: Taher Abu Hejleh, et al.
Published: (2024-04-01)

Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations
by: Sai-Hong Ignatius Ou, MD, et al.
Published: (2023-10-01)

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
by: Margaret R. Smith, et al.
Published: (2023-03-01)

Establishment and Optimization of Radiomics Algorithms for Prediction of KRAS Gene Mutation by Integration of NSCLC Gene Mutation Mutual Exclusion Information
by: Jingyi Wang, et al.
Published: (2022-04-01)

Co-Occurrence of ALK rearrangement and KRAS G12C mutation in NSCLC: Report of two cases
by: M Siringo, et al.
Published: (2024-06-01)

Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)
by: Jiyun Lee, MD, et al.
Published: (2022-01-01)

Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients
by: Arsela Prelaj, et al.
Published: (2023-01-01)

The role of distinct co-mutation patterns with TP53 mutation in immunotherapy for NSCLC
by: Shuhang Wang, et al.
Published: (2022-01-01)

Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC
by: Alissa J. Cooper, MD, et al.
Published: (2022-09-01)

Real-World Data of Combined Immunochemotherapy in Patients With Nonsquamous Advanced NSCLC. A Single-Center Retrospective Study
by: Till Wallrabenstein, MD, et al.
Published: (2023-05-01)

A Narrow NGS Panel in the Analysis of KRAS p.G12C Mutation in Longitudinal Series of NSCLC Patients: A Pilot Study
by: F. Pepe, et al.
Published: (2023-11-01)

KRAS mutated Non‐Small Lung Carcinoma: A Real World Context from the Indian subcontinent
by: Ullas Batra, et al.
Published: (2023-02-01)

Role of silent mutations in KRAS-mutant tumors
by: Jun Lu, et al.
Published: (2025-02-01)

Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens
by: Claudia Scimone, et al.
Published: (2024-03-01)

KRAS G12C mutation in NSCLC in a small genetic center: insights into sotorasib therapy response potential
by: Metin Eser, et al.
Published: (2024-11-01)

Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer
by: Huiping Qiang, et al.
Published: (2025-03-01)

COVID-19 vaccination is associated with enhanced efficacy of anti-PD-(L)1 immunotherapy in advanced NSCLC patients: a real-world study
by: Yunfei Qian, et al.
Published: (2023-09-01)

Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms
by: Zhichao Liu, et al.
Published: (2022-09-01)

Gut resistome of NSCLC patients treated with immunotherapy
by: Ewelina Iwan, et al.
Published: (2024-08-01)

Abnormalities in the KRAS Gene and Treatment Options for NSCLC Patients with the G12C Mutation in This Gene—A Literature Review and Single-Center Experience
by: Anna K. Rekowska, et al.
Published: (2024-01-01)

The Landscape of Immunotherapy Resistance in NSCLC
by: Daniele Frisone, et al.
Published: (2022-04-01)

Characterization of KRAS Mutational Regression in Oligometastatic Patients
by: Alessandro Ottaiano, et al.
Published: (2022-07-01)

Mutation in the kras gene as a predictor of the effectiveness of immunotherapy for non-small cell lung cancer
by: K. K. Laktionov, et al.
Published: (2022-03-01)

Clinical Significance of the KRAS Mutation
by: Sead Beganovic
Published: (2010-10-01)

Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges
by: Chengwei Jin, et al.
Published: (2024-12-01)

Exploring practical experience with different treatments in NSCLC patients with MET-deregulated: a retrospective analysis from the real world
by: Mengmeng Li, et al.
Published: (2025-01-01)

Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations
by: Jiaqi Li, et al.
Published: (2024-03-01)